Tuesday, March 19, 2024
ISSN 2765-8767
  • Home
  • About Us
  • Contact us
  • Support Us
  • Home
  • About Us
  • Contact us
  • Support Us

Novavax’s Covid-19 vaccine may face severe uptake challenges in the US

Novavax has released positive results from its pivotal PREVENT-19 trial of its Covid-19 vaccine, which enrolled almost 30,000 participants at 119 sites across the US and Mexico. Due to decreasing vaccination rates and high supplies of messenger ribonucleic acid (mRNA) vaccines, this vaccine may not experience much uptake in the US. A large amount of the first available doses will likely go to other countries that have a more urgent need for vaccines.

NVX-CoV2373 can serve as an alternative to adenovirus vector-based vaccines because of its easier storage requirements and higher efficacy levels. This vaccine should also be less expensive than the mRNA options, and therefore be more accessible to lower-income countries.

The trial results show that NVX-CoV2373 was 93% effective against the predominant SARS-CoV-2 variants in the trial population in the US and Mexico. A relatively high percentage of the 77 subjects who contracted Covid-19 were sequenced in this trial. Two cases were found to be caused by variant B.1.351 (Beta) and 35 caused by variant B.1.1.7 (Alpha), while the causes of the other cases were undisclosed.

Source: Clinical Trials Arena

Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Videos

Why are health insurance premiums going up?

How do you envision death?

How do you envision death?

As society entered the era of modern medicine, people developed a new understanding of death. Artist John Downman portrays two star-crossed lovers meeting for the last time: Edwin and Emma. For these two lovers, death is a welcomed reprieve from a life of sadness and separation.

Read more

Newsletter

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do